Zhao, Ping
Wu, Jun
Lu, Feiteng
Peng, Xuan
Liu, Chenlin
Zhou, Nanjin
Ying, Muying
Funding for this research was provided by:
The National Nature Science Foundation of China (31160233)
the Science and Technology Foundation of Jiangxi Province (20142BAB204013)
Graduate Student Innovation Special Foundation of Jiangxi Province (YC2018-S087)
Article History
Received: 22 April 2018
Accepted: 28 February 2019
First Online: 6 March 2019
Change Date: 27 March 2019
Change Type: Correction
Change Details: Following publication of the original article [1], it was noticed that Fig. 3c was omitted from the final published article.
Ethics approval and consent to participate
: The study protocol was reviewed and approved by the Ethics Review Committee of the Taizhou Hospital of Zhejiang Province. All procedures performed in studies involving human participants were performed in accordance with the ethical standards of the institutional and national research committees. The research poses no more than minimal risk to patients and includes appropriate safeguards to protect the patients’ rights, safety and privacy. The informed consent requirement has been waived by Ethics Review Committee of the Taizhou Hospital of Zhejiang Province.Ethical approval and informed consent were not required for the use of the reported cell lines in the present study because A549, LTEP-α-2, NCI-H1703 and QSG-7701 are established cell lines.
: Not applicable.
: The authors have no competing interests to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.